Michael John Dickinson

48PUBLICATIONS
269CO-AUTHORS
Separation technologiesOncology and carcinogenesis not elsewhere classifiedHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (48)

|Aug 14, 2026
Shortened axi-cel manufacturing drives rapid in vivo expansion and shifts the acute toxicity profile in R/R LBCL.

|Jul 16, 2026
Englumafusp alfa plus glofitamab in B cell non-Hodgkin lymphoma: a phase 1 trial.

|Jun 11, 2026
High-Dose Methotrexate as CNS Prophylaxis in Ultra High-Risk Large B-Cell Lymphoma: An International Multicenter Analysis.

|May 05, 2026
Safety and efficacy of allogeneic CD19-directed CAR-T therapy CTX110 in relapsed/refractory B-cell non-Hodgkin lymphoma.

|Apr 23, 2026
Glofitamab monotherapy in patients with Richter transformation: safety and efficacy from a phase 1 study.

|Apr 21, 2026
Impact of peri-transplant consolidative radiotherapy in patients with relapsed or refractory classical Hodgkin lymphoma.

Pageof 8

Frequent Collaborators

9 joint publications

Chan Y Cheah

9 joint publications

Nada Hamad

8 joint publications

Matthew Ku

6 joint publications

Adrian Minson